| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |